Erratum: Leiter et al. Review of Evolocumab for the Reduction of LDL Cholesterol and Secondary Prevention of Atherosclerotic Cardiovascular Disease. Reviews in Cardiovascular Medicine. 2024; 25: 190

• Lawrence A. Leiter,
• Robert A. Hegele,
• Vivien Brown,
• Jean Bergeron,
• Erin S. Mackinnon,
• G. B. John Mancini

Affiliations

Lawrence A. Leiter

Li Ka Shing Knowledge Institute, St. Michael’s Hospital, University of Toronto, Toronto, ON M5S 1A8, Canada

Robert A. Hegele

Departments of Medicine and Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, ON N6A 5C1, Canada

Vivien Brown

Department of Family and Community Medicine, Temerty Faculty of Medicine, University of Toronto, Toronto, ON M5G 1V7, Canada

Jean Bergeron

Departments of Laboratory Medicine and Medicine, Centre Hospitalier Universitaire de Québec, Université Laval, Québec, QC G1V 4G2, Canada

Erin S. Mackinnon

Amgen Canada Inc., ON L5N 0A4, Canada

G. B. John Mancini

Centre for Cardiovascular Innovation, Division of Cardiology, University of British Columbia, Vancouver, BC V5Z 1M9, Canada